ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma
Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia
Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO
Phase II Study Finds Dasatinib May Overcome ALL Resistance
Sarcoma Survivors At Risk Of Blood Clots, Study Finds
Risk of Lymphoma Increases with Hepatitis C Virus Infection
Long-Term Results Find Cisplatin Improves Survival
Study Links Ovarian Cancer To Hormone Replacement
Smokers Who Quit Live Longer Than Those Who Spit-Study
FDA Approves New Drug for Advanced Kidney Cancer
FDA Approves New Indication For Anticoagulant Frangmin
NCI-Approved Group, Center Clinical Trials Listed
Trending Stories
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B
- Trump et al. focus on NIH, cancer—and how peer review is done
- Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs - Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - In The Headlines: When DOGE fires you from your dream job
